Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4645032 | 0.98 | PTPN1 (0.58) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL23111380 | 0.94 | PTPRC (0.59) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL17439396 | 0.94 | MAPT (0.55) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL2252533 | 0.94 | CA1 (0.57) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL7451901 | 0.94 | CA1 (0.57) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL2997273 | 0.90 | PTPN1 (0.54) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL10885799 | 0.89 | CA1 (0.53) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL7786812 | 0.89 | CA1 (0.57) | PTPN1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL30629120 | 0.89 | CA1 (0.57) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 | |
| SCHEMBL8076766 | 0.89 | CA1 (0.57) | PTPN1MAPTTDP1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420444-A | Method for synthesizing benzaldehyde compound by immobilization and cooperative visible light catalysis | 华中师范大学 | 2024-08-02 | — | — | CN | claimed |
| CN-118420445-A | Method for synthesizing benzaldehyde compound by selective catalysis of visible light | 华中师范大学 | 2024-08-02 | — | — | CN | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| US-3968131-A | POLYOXYETHYLENE GLYCOL | BASF AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | claimed |
| CN-118420445-A | Method for synthesizing benzaldehyde compound by selective catalysis of visible light | 华中师范大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-118420444-A | Method for synthesizing benzaldehyde compound by immobilization and cooperative visible light catalysis | 华中师范大学 | 2024-08-02 | — | — | CN | disclosed |
| US-20230159706-A1 | FREE-RADICAL PHOTOINITIATORS AND USES OF SAME IN SILICONE COMPOSITIONS | UNIVERSITE DE HAUTE ALSACE (FR) | 2023-05-25 | — | — | US | disclosed |
| EP-3369780-B1 | METHOD FOR MANUFACTURING SUBSTRATE AND METHOD FOR MANUFACTURING LIGHT EMITTING ELEMENT USING SAME | TORAY INDUSTRIES (JP) | 2022-10-26 | — | — | EP | disclosed |
| CN-111956636-B | Application of 2-substituted anthraquinone derivative in preparation of medicines for treating candida albicans infection | 中国药科大学 | 2022-03-18 | — | — | CN | disclosed |
| US-20220025130-A1 | ISOLATION METHOD FOR WATER INSOLUBLE LIGNIN COMPONENTS OF A BIOMASS | GREEN EXTRACTION TECHNOLOGIES | 2022-01-27 | — | — | US | disclosed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-4812489-A | URETHANE ACRYLATE OLIGOMER, TRIS(2-HYDROXYETHYL)ISOCYANURATE TRIACRYLATE, REACTIVE DILUENT, AND A PHOTOPOLYMERIZATION INIATOR; CLADDING, BUFFER MATERIALS FOR OPTICAL FIBER UNITS | THE YOKOHAMA RUBBER CO., LTD. (JP) | 1989-03-14 | — | — | US | disclosed |
| EP-0284027-A2 | Anaerobically curing adhesive sealing composition | THREE BOND CO., LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
| US-4739062-A | REACTING AN AROMATIC COMPOUND WITH DICARBOXYLIC ACID COMPOUND USING METAL HALIDE CATALYST | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1988-04-19 | — | — | US | disclosed |
| EP-0212329-A1 | Process for the delignification of cellulosic materials | INTEROX Société Anonyme (BE) | 1987-03-04 | — | — | EP | disclosed |
| EP-0049221-B1 | PROCESS FOR THE DELIGNIFICATION OF LIGNOCELLULOSIC MATERIAL | CIBA-GEIGY AG (CH) | 1983-12-21 | — | — | EP | disclosed |
| EP-0049221-A1 | Process for the delignification of lignocellulosic material | CIBA-GEIGY AG (CH) | 1982-04-07 | — | — | EP | disclosed |
| US-3968131-A | POLYOXYETHYLENE GLYCOL | BASF AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | PTPN1 2166/4885MAPT 2071/4885TDP1 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.